Welcome to the Cardiogenics Holdings Discussion Forum

Paramagnetic Beads and QL Analyser are Proprietary Products

Free
Message: Charlie Lewner - 5,000,0000 share purchase
FRIDAY, 22 MAY 2015
FEATURED NEWS
  • Lewner Charlie Just Reported Giant Cardiogenics Holdings Inc Stake
05/20/2015 BY OCTASTAFF IN SEC 13G & 13D FILINGS

Lewner Charlie New Position in CardioGenics Holdings Inc (OTCMKTS:CGNH)

Lewner Charlie has filled a SC 13G form regarding Cardiogenics Holdings Inc 0.0350 -0.0038 -9.79%.Per Lewner Charlie’s filing, the filler now owns 5.7% of the company, holding 5,000,000 shares.

CardioGenics Holdings Inc (OTCMKTS:CGNH) is a newly disclosed equity position and the filing was required due to activity on February 23, 2015 . This most probably shows Lewner Charlie’s confidence and optimism in the future of the company.

Company Profile

CardioGenics Holdings Inc. is a Canada-based development-stage company. The Company develops technology and products targeting the immunoassay segment of the in vitro diagnostic (IVD) testing market. The Company’s products include: QL Care Analyzer (QLCA), Cardiovascular Tests and Paramagnetic Beads. The QLCA represents a shift in the design of point-of-care (POC) analyzers. To support the use of the QLCA, the Company has developed four immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack. These tests include Troponin I (TnI), Plasminogen Activator Inhibitor Type-1 (PAI-1), Heart Failure Risk Stratification (HFRS) and Heart Failure Genomics Risk (HFGR). Pramagnetic (magnetic) beads are the common solid phase employed during immunoassays tests in these laboratories. The Company has developed a process that coats the beads with a layer of silver, making them white and more sensitive to light.

Form 13G is used when the filer owns between 5% and 20% of the company and plans to hold it only as a passive investor. If the filler intend to exert control and if the stake’s size exceeds 20%, then a 13D must be filed. Therefore, activist investors and practices such as: hostile takeovers, company breakups, and other “change of control” events, are not permitted by 13G filers.

Share
New Message
Please login to post a reply